Presentation of a comparison between digital and glass slide histology from screening biopsies in the Phase 3 NATiV3 studyPresentation of digital ...

The Phase 1b trial will evaluate the safety and tolerability of cemsidomide, an IKZF1/3 degrader, and dexamethasone in combination with elranatamab as a second line or later therapy for patients with ...

In her lawsuit, Melissa Tempel claimed her firing was in retaliation for comments she made on the social media platform ...

May Faculty and Staff GrantsRestrictedCasey Myers, Ritchie School of Engineering & Computer ScienceFunder: RestrictedAbstract ...

In-the-wild testing of police facial recognition systems has failed to generate clear evidence of the technology’s benefits, ...

FLASH 2 Study Interim Efficacy Analysis Targeted for 1H2026 Enrollment Update Remains on Track for 4Q2025 PRINCETON, N.J., Oct. 7, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...

Graphano Energy Ltd. (TSXV: GEL) (OTC Pink: GELEF) (FSE: 97G0) (“Graphano” or the “Company”) is pleased to report initial assay ...

Yunqi Capital Limited (together with its affiliates and the funds it advises, "Yunqi Capital"), an investment management firm and 5.1% shareholder of STAAR Surgical Company ("STAAR" or the "Company") ...

C3 Metals Inc. (TSXV: CCCM) (OTCQB: CUAUF) (“C3 Metals” or the “Company”) is pleased to announce it has commenced a 3DIP ...

Detailed price information for Tenaz Energy Corp (TNZ-T) from The Globe and Mail including charting and trades.

Detailed price information for Biomea Fusion Inc (BMEA-Q) from The Globe and Mail including charting and trades.